[1] Sung H, Ferlay J, Siegel RL, et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin, 2021, 71(3):209-249.
[2] Arnold M, Morgan E, Rumgay H, et al.Current and future burden of breast cancer:Global statistics for 2020 and 2040[J].Breast, 2022, 66:15-23.
[3] Darlix A, Louvel G, Fraisse J, et al.Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort[J].Br J Cancer, 2019, 121(12):991-1000.
[4] Kadry H, Noorani B, Cucullo L.A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity[J].Fluids Barriers CNS, 2020, 17:1-24.
[5] Mofatteh M, Mashayekhi MS, Arfaie S, et al.Suicidal ideation and attempts in brain tumor patients and survivors:A systematic review[J].Neurooncol Adv, 2023, 5(1):vdad058.
[6] Luo T, Kang Y, Liu Y, et al.Small extracellular vesicles in breast cancer brain metastasis and the prospect of clinical application[J].Front Bioeng Biotechnol, 2023, 11:1162089.
[7] Da Mesquita S, Louveau A, Vaccari A, et al.Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease[J].Nature, 2018, 560(7717):185-191.
[8] Curtaz CJ, Schmitt C, Herbert SL, et al.Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood-brain barrier model[J].Fluids Barriers CNS, 2020, 17:1-12.
[9] Xiao W, Zheng S, Xie X, et al.SOX2 promotes brain metastasis of breast cancer by upregulating the expression of FSCN1 and HBEGF[J].Mol Ther Oncolytics, 2020, 17:118-129.
[10] Tamura T, Yoshioka Y, Sakamoto S, et al.Extracellular vesicles in bone metastasis:Key players in the tumor microenvironment and promising therapeutic targets[J].Int J Mol Sci, 2020, 21(18):6680.
[11] Chow BW, Gu C.The molecular constituents of the blood-brain barrier[J].Trends Neurosci, 2015, 38(10):598-608.
[12] Zhou W, Fong MY, Min Y, et al.Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis[J].Cancer Cell, 2014, 25(4):501-515.
[13] Tominaga N, Kosaka N, Ono M, et al.Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier[J].Nat Commun, 2015, 6(1):6716.
[14] András IE, Toborek M.Extracellular vesicles of the blood-brain barrier[J].Tissue Barriers, 2016, 4(1):e1131804.
[15] Morad G, Daisy CC, Otu HH, et al.Cdc42-dependent transfer of mir301 from breast cancer-derived extracellular vesicles regulates the matrix modulating ability of astrocytes at the blood-brain barrier[J].Int J Mol Sci, 2020, 21(11):3851.
[16] Chan BD, Wong WY, Lee MML, et al.Exosomes in inflammation and inflammatory disease[J].Proteomics, 2019, 19(8):1800149.
[17] Abdelsalam M, Ahmed M, Osaid Z, et al.Insights into exosome transport through the blood-brain barrier and the potential therapeutical applications in brain diseases[J].Pharmaceuticals, 2023, 16(4):571.
[18] Sakamoto Y, Ochiya T, Yoshioka Y.Extracellular vesicles in the breast cancer brain metastasis:physiological functions and clinical applications[J].Front Hum Neurosci, 2023, 17:1278501
[19] Yang C, Wu Y, Wang L, et al.Glioma-derived exosomes hijack the blood-brain barrier to facilitate nanocapsule delivery via LCN2[J].J Control Release, 2022, 345:537-548.
[20] Rodrigues G, Hoshino A, Kenific CM, et al.Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis[J].Nat Cell Biol, 2019, 21(11):1403-1412.
[21] Marleau AM, Chen CS, Joyce JA, et al.Exosome removal as a therapeutic adjuvant in cancer[J].J Transl Med, 2012, 10:1-12.
[22] Qiu Y, Yang Y, Yang R, et al.Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer[J].Oncogene, 2021, 40(31):4992-5001.
[23] Nishida-Aoki N, Tominaga N, Kosaka N, et al.Altered biodistribution of deglycosylated extracellular vesicles through enhanced cellular uptake[J].J Extracell Vesicles, 2020, 9(1):1713527.
[24] Huang LY, Song JX, Cai H, et al.Healthy serum-derived exosomes improve neurological outcomes and protect blood-brain barrier by inhibiting endothelial cell apoptosis and reversing autophagy-mediated tight junction protein reduction in rat stroke model[J].Front Cell Neurosci, 2022, 16:841544.
[25] Kim KA, Kim D, Kim JH, et al.Autophagy-mediated occludin degradation contributes to blood-brain barrier disruption during ischemia in bEnd.3 brain endothelial cells and rat ischemic stroke models[J].Fluids Barriers CNS, 2020, 17:1-12.
[26] Mostafazadeh M, Kahroba H, Haiaty S, et al.In vitro exosomal transfer of Nrf2 led to the oxaliplatin resistance in human colorectal cancer LS174T cells[J].Cell Biochem Funct, 2022, 40(4):391-402.
[27] Nawaz M, Heydarkhan-Hagvall S, Tangruksa B, et al.Lipid nanoparticles deliver the therapeutic VEGFA mRNA in vitro and in vivo and transform extracellular vesicles for their functional extensions[J].Adv Sci(Weinh), 2023, 10(12):2206187.
[28] Jiang Y, Wang F, Wang K, et al.Engineered exosomes:a promising drug delivery strategy for brain diseases[J].Curr Med Chem, 2022, 29(17):3111-3124.
[29] Prunevieille A, Babiker-Mohamed MH, Aslami C, et al.T cell antigenicity and immunogenicity of allogeneic exosomes[J].Am J Transplant, 2021, 21(7):2583-2589.
[30] Mehryab F, Rabbani S, Shahhosseini S, et al.Exosomes as a next-generation drug delivery system:An update on drug loading approaches, characterization, and clinical application challenges[J].Acta Biomater, 2020, 113:42-62.
[31] Shetgaonkar GG, Marques SM, DCruz CEM, et al.Exosomes as cell-derivative carriers in the diagnosis and treatment of central nervous system diseases[J].Drug Deliv Transl Res, 2022, 12(5):1047-1079.
[32] Silachev DN, Goryunov KV, Shpilyuk MA, et al.Effect of MSCs and MSC-derived extracellular vesicles on human blood coagulation[J].Cells, 2019, 8(3):258.
